South San Francisco
California, United States of America
The Digital Health Platforms (DHP) group at Roche/Genentech is part of the Personalized Healthcare (PHC) Center of Excellence focusing on developing the next generation digital health platforms, tools and products for the future of medicine. Digital health promises to revolutionize how we diagnose disease, understand a patient’s disease course and response to treatment with unprecedented precision, and predict what treatment strategies are likely to be optimal. We are building a clinically validated, highly scalable and secure software platform with regulatory, quality, and privacy requirements. Our platform and services support advanced analysis of data captured and transmitted from apps, tools, Software as Medical Device (SaMDs), connected medical devices, and combination products.
DHP partners across the company with other Digital Health groups to advance digital health solutions which include hardware, software, applications, tools, and platforms to enable development of our therapies as well as more personalized care of patients across a range of therapeutic areas. Our primary focus is on the validation, scaling, and productization of digital health platforms, tools, and products; inclusive of late-stage development of novel digital biomarkers and endpoints, as well as the design, conduct, and analysis of analytical validation, clinical validation, and clinical utility studies to meet clinical and regulatory requirements, as appropriate.
The PHC Center of Excellence is focused on translating the promise of meaningful data at scale, advanced analytics, and digital technologies for drug development, and personalized patient care.
The Platform Measurement Science group within DHP provides scientific and clinical expertise to support ideation & identification, development, validation and safe & effective use of digital biomarkers and endpoints, digital health platforms, tools, capabilities, and products in our portfolio. Our priorities will be to bring customer-focus, especially understanding of the meaningfulness of digital health measures for patients and healthcare providers, scaling from prototypes to clinical and commercial in-market deployment, as well as making the most effective use of generated data in ensuring that our digital health platforms bring value to patients.
We closely collaborate within Roche with our other DHP groups, clinical development functions, other digital health groups, functions and subject matter experts within the Personalized Healthcare area and the Research and Early Development organizations, Diagnostics, Pharma Partnering, and technical & technology functions, in order to define and execute the strategic direction of Digital Health to transform drug development and patient care. We externally partner with patient groups and health care providers, technology companies, regulatory and reimbursement authorities, policy makers and others.
The Senior Principal Measurement Scientist in Digital Health Platforms for Ophthalmology will maintain scientific oversight through:
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech